StockNews.com assumed coverage on shares of OptimumBank (NASDAQ:OPHC – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the bank’s stock.
Separately, Compass Point began coverage on OptimumBank in a research report on Thursday, May 23rd. They issued a neutral rating and a $5.25 price objective for the company.
View Our Latest Stock Report on OptimumBank
OptimumBank Trading Up 1.1 %
OptimumBank (NASDAQ:OPHC – Get Free Report) last posted its quarterly earnings data on Monday, August 5th. The bank reported $0.34 earnings per share (EPS) for the quarter. OptimumBank had a net margin of 18.24% and a return on equity of 12.66%. The company had revenue of $9.94 million for the quarter.
Institutional Investors Weigh In On OptimumBank
Several institutional investors and hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP boosted its position in shares of OptimumBank by 52.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 26,114 shares of the bank’s stock valued at $112,000 after acquiring an additional 8,960 shares in the last quarter. Renaissance Technologies LLC lifted its stake in OptimumBank by 21.4% during the second quarter. Renaissance Technologies LLC now owns 52,428 shares of the bank’s stock worth $225,000 after purchasing an additional 9,228 shares during the period. Finally, EJF Capital LLC acquired a new stake in OptimumBank during the first quarter valued at approximately $1,100,000. Institutional investors own 7.43% of the company’s stock.
About OptimumBank
OptimumBank Holdings, Inc operates as the bank holding company for OptimumBank that provides various consumer and commercial banking services to individuals and businesses. It accepts demand interest-bearing and noninterest-bearing, savings, money market, and NOW accounts, as well as time deposits, wire transfers, ACH services, and certificates of deposit.
See Also
- Five stocks we like better than OptimumBank
- ESG Stocks, What Investors Should Know
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- What Investors Need to Know About Upcoming IPOs
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is the Dogs of the Dow Strategy? Overview and Examples
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for OptimumBank Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimumBank and related companies with MarketBeat.com's FREE daily email newsletter.